Max Delbrück Center
Register
Register
Register

MyImmune Corporation

Therapeutics & Diagnostics

www.myimmune.ai/Wilmington, United States
5 profile visits

About

MyImmune (also known as MyImmune Corporation) is a precision medicine biotechnology company focused on decoding the human immune system to transform disease diagnosis and treatment. Founded in 2024 and leveraging research from Osaka University, the company utilizes an advanced artificial intelligence platform to analyze adaptive immune receptor data (such as B-cell and T-cell receptors). Their technology aims to predict patient responses to immunotherapies and diagnose conditions like cancer, autoimmune disorders, and neurodegenerative diseases rapidly through a single blood test, ultimately enabling more personalized and effective therapeutic strategies.

Disease Area

CancerInflammation / Autoimmune DiseasesInfectious DiseasesNeurological Diseases

Biomedical Research, Medicine, Human Health

Drug Target DiscoveryBiomarker DiscoveryEarly DetectionDiagnosticsLiquid BiopsyTherapy MonitoringClinical Research, Trials

Technology

Data science, AI / Machine learning

Representatives

Co-founder & CEO MyImmune

MyImmune Corporation